Patent ID: 8101598

Claim:
A method of treatment of a cognitive disorder, a learning deficit, a memory deficit or dysfunction, Alzheimer's disease, attention deficit, attention deficit hyperactivity disorder (ADHD), schizophrenia, a cognitive or attention deficit related to schizophrenia, AIDS-dementia, senile dementia, senile dementia of the Alzheimer's type, an inflammatory disorder, Crohn's disease, inflammatory bowel disease, or ulcerative colitis, which method comprises administering to a living animal body in need thereof a therapeutically effective amount of a 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compound represented by Formula I, or a pharmaceutically-acceptable salt thereof, wherein Ar represents a phenyl group, which phenyl is substituted with methylenedioxy or ethylenedioxy.